Electromed Inc (A:ELMD)
Business Focus: Advanced Medical Equipment & Technology
Apr 08, 2024 04:05 pm ET
Electromed, Inc. to Participate in the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 17-18, 2024.
Mar 12, 2024 10:30 am ET
Sidoti Events, LLC's Virtual March Small-Cap Conference
NEW YORK, NY / ACCESSWIRE / March 12, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 13-14, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Feb 28, 2024 08:30 am ET
Electromed, Inc. to Participate in the 2024 Sidoti March Small-Cap Virtual Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti March Small-Cap Virtual Conference on March 13-14, 2024.
Feb 13, 2024 04:05 pm ET
Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2023 (“Q2 FY 2024”).
Jan 30, 2024 08:30 am ET
Electromed, Inc. Schedules its Second Quarter Fiscal 2024 Financial Results Conference Call for February 13, 2024 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 second quarter ended December 31, 2023, on February 13, 2024 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Jan 29, 2024 08:30 am ET
Electromed, Inc. Announces Partnership to Expand SmartVest Access to Veterans, Federal Employees, and Native American Communities
Electromed, Inc. (NYSE American: ELMD) today announced it has entered into a distribution agreement with Marathon Medical Corp., a medical supply distribution company and service-disabled veteran-owned small business (SDVOSB). SmartVest® Airway Clearance System, which is designed for High Frequency Chest Wall Oscillation (“HFCWO”) therapy, a clinically proven therapy that helps clear the lungs of excess secretions, thereby reducing the risk of respiratory infections and hospitalizations for those suffering from a chronic lung condition.1 As a distribution partner, Maratho
Jan 24, 2024 08:30 am ET
Electromed, Inc. to Participate in the Virtual 2024 Lytham Partners Investor Select Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the virtual 2024 Lytham Partners Investor Select Conference on February 1, 2024.
Nov 07, 2023 04:05 pm ET
Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2023 (“Q1 FY 2024”).
Nov 01, 2023 04:05 pm ET
Electromed, Inc. Announces Hospital Market Release SmartVest Clearway, Fifth Generation HFCWO Airway Clearance Generator
Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced its launch of the SmartVest® Clearway® Airway Clearance System to the hospital market for inpatient use. The SmartVest Clearway system, which is designed for High Frequency Chest Wall Oscillation (“HFCWO”) therapy, offers an updated and efficient approach to pulmonary hygiene in the inpatient setting with proven patient outcomes.1
Nov 01, 2023 08:30 am ET
Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023 at the Westin NY Grand Central in New York City.
Oct 24, 2023 08:30 am ET
Electromed, Inc. Schedules its First Quarter Fiscal 2024 Financial Results Conference Call for November 7, 2023 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2024 first quarter ended September 30, 2023, on Tuesday, November 7, 2023 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Aug 22, 2023 04:05 pm ET
Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2023”) and full year (“FY 2023”) ended June 30, 2023.
Aug 08, 2023 04:05 pm ET
Electromed, Inc. Schedules its Fourth Quarter Fiscal 2023 Financial Results Conference Call for August 22, 2023 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 fourth quarter and year ended June 30, 2023, on Tuesday, August 22, 2023 after the close of the stock market. Company management will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Jul 07, 2023 04:05 pm ET
Electromed Announces Grant of Inducement Equity Awards
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it granted equity awards on July 1, 2023 as a material inducement to employment of James L. Cunniff, the newly appointed President and Chief Executive Officer of Electromed.
Jun 13, 2023 08:00 am ET
Sidoti Events, LLC's Virtual June Small-Cap Conference
NEW YORK, NY / ACCESSWIRE / June 13, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 14-15, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Jun 06, 2023 09:00 am ET
Electromed, Inc. to Participate in the Sidoti Summer Small Cap Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the virtual Sidoti Summer Small Cap Conference on June 14-15, 2023.
Jun 05, 2023 08:15 am ET
Electromed Names Jim Cunniff as President and Chief Executive Officer
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced the appointment of Jim Cunniff as its new President and Chief Executive Officer (CEO), effective July 1, 2023. Mr. Cunniff will also join Electromed’s Board of Directors.
May 09, 2023 04:05 pm ET
Electromed, Inc. Announces Fiscal 2023 Third Quarter Results
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2023 (“Q3 FY 2023”).
Apr 27, 2023 09:00 am ET
Electromed, Inc. to Participate in the Inaugural EF Hutton Global Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Inaugural EF Hutton Global Conference on May 10-11, 2023 at the Plaza Hotel in New York, New York. Management will be available for one-on-one meetings on Thursday, May 11, 2023.
Apr 25, 2023 04:21 pm ET
Electromed, Inc. Schedules its Third Quarter Fiscal 2023 Financial Results Conference Call for May 9, 2023 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 third quarter ended March 31, 2023, on Tuesday, May 9, 2023 after the close of the stock market, and host a conference call at the same day at 5:00 p.m. Eastern Time to discuss the results.
Feb 14, 2023 04:10 pm ET
Electromed, Inc. Announces Fiscal 2023 Second Quarter Results
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2022 (“Q2 FY 2023”).
Feb 14, 2023 04:05 pm ET
Electromed Announces Chief Executive Officer Retirement and Succession Plan
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan will retire as President and Chief Executive Officer with a target effective date on or around July 1, 2023. After her retirement she will serve as a non-employee member and chair of the company’s board of directors. The Board of Directors is conducting a comprehensive search to identify a new President and CEO and engaged a national executive search firm to assist in the process.
Jan 31, 2023 04:05 pm ET
Electromed, Inc. Schedules its Second Quarter Fiscal 2023 Financial Results Conference Call for February 14, 2023 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 second quarter ended December 31, 2022, on Tuesday, February 14, 2023 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Nov 30, 2022 09:00 am ET
Electromed, Inc. Announces U.S. Food and Drug Administration 510(k) Clearance of Fifth Generation HFCWO Airway Clearance Generator
Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced that it received U.S Food and Drug Administration (“FDA”) 510(k) clearance of the SmartVest® Clearway® Airway Clearance System, which is designed for High Frequency Chest Wall Oscillation (“HFCWO”) therapy. The SmartVest Clearway system, an updated and modern approach to HFCWO, offers an enhanced patient experience with proven patient outcomes.1
Nov 08, 2022 04:05 pm ET
Electromed, Inc. Announces Fiscal 2023 First Quarter Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2022 (“Q1 FY 2023”).
Nov 08, 2022 03:40 pm ET
Sidoti's November Micro-Cap Virtual Conference
NEW YORK, NY / ACCESSWIRE / November 8, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day November Micro-Cap Conference taking place Wednesday and Thursday, November 9-10, 2022. The links can also be found at www.sidoticonference.com/events .
Nov 03, 2022 09:00 am ET
Electromed, Inc. to Participate in Two Upcoming Investor Conferences
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that management is scheduled to participate in two upcoming investor conference during the month of November 2022:
Oct 25, 2022 09:00 am ET
Electromed, Inc. Schedules its First Quarter Fiscal 2023 Financial Results Conference Call for November 8, 2022 at 5:00 p.m. PT
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 first quarter ended September 30, 2022, on Tuesday, November 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Oct 24, 2022 09:00 am ET
Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Brad Nagel as the Company’s Chief Financial Officer, effective November 14, 2022.
Sep 28, 2022 04:05 pm ET
Electromed, Inc. to Participate in the Issuer Direct 2022 Windy City Roundup
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate at the Issuer Direct 2022 Windy City Roundup on October 12-13, 2022. Management will be available for one-on-one investor meetings throughout both days. Below are the details for Electromed’s group presentation:
Sep 27, 2022 09:05 am ET
60+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in Chicago
RALEIGH, NC / ACCESSWIRE / September 27, 2022 / The 2nd Annual MicroCap Rodeo Conference is going on the road and will take place at the Swissotel in Chicago on October 12th - 13th, 2022, where 60+ SmallCap, MicroCap and NanoCap public companies will be presenting to a global investor audience.
Aug 23, 2022 04:05 pm ET
Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2022”) and full year (“FY 2022”) ended June 30, 2022.
Aug 02, 2022 04:05 pm ET
Electromed, Inc. Schedules its Fourth Quarter and Fiscal 2022 Financial Results Conference Call for August 23, 2022 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 fourth quarter and fiscal year 2022, ended June 30, 2022, after the close of the stock market on August 23, 2022. The Company will host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Jul 25, 2022 08:30 am ET
Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it has elected a new independent director, Andrew Summers, to its Board of Directors, effective July 25, 2022. In connection with the election, Electromed has entered into a new cooperation agreement with Summers Value Partners LLC (“Summers Value Partners”), an investment firm that beneficially owns approximately 6.1% of Electromed’s outstanding common stock. Mr. Summers has also been appointed to serve as the Vice Chair of the Strategy and Finance Committee and a
Jul 19, 2022 04:05 pm ET
Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate in the Canaccord Genuity 42nd Annual Growth Conference on August 8-11, 2022. Management will be available for investor one-on-ones on Wednesday, August 10, 2022.
May 19, 2022 09:00 am ET
Electromed, Inc. Announces Clinical Abstract Poster at ATS Conference: Bronchiectasis Patients Showed Improved Outcomes and Reduction in Healthcare Resource Utilization When Using HFCWO Therapy
Electromed, Inc. (NYSE American: ELMD) today announced the results of a third-party, clinical study presented as a clinical abstract poster at the American Thoracic Society International Conference in San Francisco, CA. The study’s key findings reveal that patients who used high frequency chest wall oscillation (“HFCWO”) therapy experienced an improvement in health outcomes, as well as a reduction in healthcare resource utilization (“HCRU”), including a reduction in medication usage.
May 10, 2022 04:05 pm ET
Electromed, Inc. Announces Third Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for its fiscal 2022 third quarter ended March 31, 2022. Management will host a conference call at 5:00 p.m. Eastern Time today to discuss the results.
May 10, 2022 07:00 am ET
Sidoti May Virtual Micro Cap Investor Conference
NEW YORK, NY / ACCESSWIRE / May 10, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day May Micro Cap Virtual Conference taking place Wednesday and Thursday, May 11th-12th, 2022. The links can also be found at www.sidoticonference.com/events.
May 03, 2022 04:05 pm ET
Electromed, Inc. to Participate in the Sidoti & Co. May Micro Cap Virtual Investor Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the Sidoti May Virtual Micro Cap Investor Conference on May 11-12, 2022. Management will be available for one-on-ones throughout both days. Below are the details for Electromed’s group presentation:
Apr 19, 2022 04:05 pm ET
Electromed, Inc. Schedules its Third Quarter Fiscal 2022 Financial Results Conference Call for May 10, 2022 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 third quarter ended March 31, 2022, on Tuesday, May 10, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Feb 16, 2022 08:30 am ET
Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced the appointment of Christopher Holland as Chief Commercial Officer.
Feb 08, 2022 04:05 pm ET
Electromed, Inc. Announces Second Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for its fiscal 2022 second quarter ended December 31, 2021. Management will host a conference call at 5:00 p.m. Eastern Time today to discuss the results.
Jan 27, 2022 04:22 pm ET
Electromed, Inc. Schedules its Second Quarter Fiscal 2022 Financial Results Conference Call for February 8, 2022 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 second quarter ended December 31, 2021, on Tuesday, February 8, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Dec 07, 2021 04:30 pm ET
Sidoti December Micro Cap Virtual Conference
Presentation Times Released for 75+ Presenting Companies
Nov 29, 2021 09:00 am ET
Electromed, Inc. to Participate in the Sidoti December Virtual Micro Cap Investor Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the Sidoti December Virtual Micro Cap Investor Conference on December 8-9, 2021. Management will be available for one-on-ones throughout both days. Below are the details for Electromed’s group presentation:
Nov 09, 2021 04:05 pm ET
Electromed, Inc. Announces Fiscal 2022 First Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2021 (“Q1 FY 2022”).
Nov 05, 2021 12:00 pm ET
Sidoti Microcap Virtual Conference
A Conference Open to All Classes of Investors70+ Companies Presenting and Meeting Interested Investors 1x1Wednesday and Thursday, December 8-9, 2021
Oct 26, 2021 04:30 pm ET
Electromed, Inc. Schedules its First Quarter Fiscal 2022 Financial Results Conference Call for November 9, 2021 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 first quarter ended September 30, 2021, on Tuesday, November 9, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Sep 27, 2021 08:00 am ET
Electromed, Inc. Announces Nominations of Kathy Tune and Joe Galatowitsch as New Independent Directors
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will nominate two new independent directors, Kathy Tune and Joe Galatowitsch, for election to its Board of Directors at the Company’s Fiscal 2022 Annual Meeting of Shareholders (the “Annual Meeting”), to be held in November. In connection with these nominations, Electromed has entered into a cooperation agreement with Summers Value Partners LLC (“Summers Value Partners”), an investment firm that beneficially owns approximately 5.9% of Electromed’
Aug 31, 2021 09:00 am ET
Electromed, Inc. to Participate in the 2021 Colliers Institutional Investor Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2021 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 9, 2021.
Aug 24, 2021 04:10 pm ET
Electromed, Inc. Announces Fiscal 2021 Fourth Quarter and Full Year Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2021”) and full year (“FY 2021”) ended June 30, 2021.
Aug 16, 2021 04:35 pm ET
Electromed, Inc. Schedules its Fourth Quarter Fiscal 2021 Financial Results Conference Call for August 24, 2021 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 fourth quarter ended June 30, 2021, on Tuesday, August 24, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Aug 13, 2021 08:00 am ET
Electromed, Inc. to Consider Director Nominations from Summers Value Partners
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today confirmed that Summers Value Partners has provided notice of its intent to nominate four candidates to stand for election to the Electromed Board of Directors at its Fiscal 2022 Annual Meeting of Shareholders (the “Annual Meeting”).
Aug 09, 2021 05:05 pm ET
Electromed, Inc. Announces Select Preliminary Unaudited Financial Results for Fourth Quarter Fiscal 2021
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced select preliminary unaudited financial results for the three months ended June 30, 2021 (“Q4 FY 2021”).
Aug 02, 2021 09:00 am ET
Electromed, Inc. to Participate in Canaccord Genuity’s 41st Annual Growth Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in Canaccord Genuity’s 41st Annual Growth Conference, to be held virtually, on August 10-12, 2021.
May 27, 2021 04:30 pm ET
Electromed, Inc. Announces Authorization of $3.0 Million Stock Repurchase Program
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has approved a $3.0 million stock repurchase authorization, effective as of May 26, 2021.
May 24, 2021 04:05 pm ET
Electromed, Inc. Named 2021 Quality Plant of the Year
Electromed, Inc. (NYSE American: ELMD) was named Quality Magazine’s 2021 Plant of the Year.
May 11, 2021 04:05 pm ET
Electromed, Inc. Announces Fiscal 2021 Third Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced its financial results for the three months ended March 31, 2021 (“Q3 FY 2021”).
Apr 27, 2021 04:30 pm ET
Electromed, Inc. Schedules its Third Quarter Fiscal 2021 Financial Results Conference Call for May 11, 2021 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 third quarter ended March 31, 2021, on Tuesday, May 11, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Mar 23, 2021 07:30 pm ET
Sidoti Virtual Investor Conference
Presentation Times and Weblinks Released for Over 125 Presenting Companies
Mar 04, 2021 09:00 am ET
Electromed, Inc. to Participate in the Sidoti Spring 2021 Virtual Investor Conference
Sidoti Spring 2021 Virtual Investor Conference
Feb 09, 2021 04:05 pm ET
Electromed, Inc. Announces Fiscal 2021 Second Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2020 (“Q2 FY 2021”).
Jan 26, 2021 04:30 pm ET
Electromed, Inc. Schedules its Second Quarter Fiscal 2021 Financial Results Conference Call for February 9, 2021 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 second quarter ended December 31, 2020 on Tuesday, February 9, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Nov 19, 2020 06:45 am ET
Sidoti Virtual Microcap Investor Conference
NEW YORK, NY / ACCESSWIRE / November 19, 2020 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for today's Virtual Microcap Investor Conference.
Nov 18, 2020 04:15 pm ET
Andrea M. Walsh Elected to Electromed, Inc. Board of Directors
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its shareholders have elected Andrea M. Walsh to serve as an additional director of the Company.
Nov 11, 2020 04:30 pm ET
Electromed, Inc. To Present at the Sidoti Virtual Microcap Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to present at the Sidoti Virtual Microcap Conference on Thursday, November 19, 2020, at 2:30 p.m. Eastern Time.
Nov 10, 2020 04:05 pm ET
Electromed, Inc. Announces Fiscal 2021 First Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2020 (“Q1 FY 2021”).
Oct 27, 2020 04:30 pm ET
Electromed, Inc. Schedules its First Quarter Fiscal 2021 Financial Results Conference Call for November 10, 2020 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 first quarter ended September 30, 2020 on Tuesday, November 10, 2020 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Aug 26, 2020 04:30 pm ET
Electromed, Inc. to Participate in the 2020 Colliers Institutional Investor Conference
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2020 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 10, 2020.
Aug 25, 2020 04:05 pm ET
Electromed, Inc. Announces Fiscal 2020 Fourth Quarter and Full Year Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended June 30, 2020 (“Q4 FY 2020”).
Aug 13, 2020 09:00 am ET
Electromed, Inc. Schedules its Fourth Quarter Fiscal 2020 Financial Results Conference Call for August 25, 2020 at 5:00 p.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2020 fourth quarter ended June 30, 2020 on Tuesday, August 25, 2020 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.
Jun 08, 2020 04:30 pm ET
Electromed, Inc. Set to Join Russell 3000® Index
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that the Company is set to join the broad-market Russell 3000® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29, according to a preliminary list of additions posted June 5, 2020.
May 18, 2020 04:30 pm ET
Electromed, Inc. Appoints Michael J. MacCourt as Chief Financial Officer
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Michael J. MacCourt as the Company’s Chief Financial Officer, effective May 26, 2020.
May 12, 2020 04:30 pm ET
Electromed, Inc. Announces Fiscal 2020 Third Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2020 (“Q3 FY 2020”).
Apr 29, 2020 04:30 pm ET
Electromed, Inc. Schedules its Third Quarter Fiscal 2020 Financial Results Conference Call for May 13, 2020 at 8:30 a.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2020 third quarter ended March 31, 2020 on Tuesday, May 12, 2020 after the close of the stock market. Management will host a conference call on Wednesday, May 13, 2020 at 8:30 a.m. Eastern Time to discuss the results.
Mar 10, 2020 04:30 pm ET
Electromed, Inc. Launches SmartVest Connect Mobile Application
Electromed, Inc. (NYSE American: ELMD) today announced the launch of its SmartVest Connect® App for iOS and Android, a personalized high frequency chest wall oscillation (HFCWO) therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest® SQL® through Bluetooth™ technology. This interface allows patients and healthcare teams to track therapy in real-time and collaborate on care decisions to improve therapy adherence and patient outcomes.
Mar 04, 2020 04:30 pm ET
Electromed, Inc. Announces CFO Transition
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that CFO Jeremy Brock has elected to pursue other opportunities and the Company and Mr. Brock have established a transition plan. Mr. Brock will continue in the role of CFO until July 1, 2020. Electromed has commenced a national search process to identify and recruit its next CFO.
Feb 11, 2020 04:30 pm ET
Electromed, Inc. Announces Fiscal 2020 Second Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended December 31, 2019 (“Q2 FY 2020”).
Jan 29, 2020 04:30 pm ET
Electromed, Inc. Schedules its Second Quarter Fiscal 2020 Financial Results Conference Call for February 12, 2020 at 8:30 a.m. ET
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2020 second quarter ended December 31, 2019 on Tuesday, February 11, 2020 after the close of the stock market. Management will host a conference call on Wednesday, February 12, 2020 at 8:30 a.m. Eastern Time to discuss the results. Please note that the conference call commences thirty minutes earlier than the Company’s historical call start time.
Nov 12, 2019 04:30 pm ET
Electromed, Inc. Announces Fiscal 2020 First Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2019 (“Q1 FY 2020”).
Oct 30, 2019 04:30 pm ET
Electromed, Inc. Schedules Release of First Quarter Fiscal 2020 Financial Results and Conference Call
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2020 first quarter ended September 30, 2019 on Tuesday, November 12, 2019 after the close of the stock market. Management will host a conference call on Wednesday, November 13, 2019 at 9:00 a.m. Eastern Time to discuss the results.
Sep 10, 2019 04:30 pm ET
Electromed, Inc. To Participate in the Sidoti & Company Fall 2019 Investor Conference
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that management will participate in the Sidoti & Company Fall 2019 Investor Conference in New York, NY on Wednesday, September 25, 2019.
Aug 27, 2019 04:30 pm ET
Electromed, Inc. Announces Fiscal 2019 Fourth Quarter and Full Year Financial Results
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended June 30, 2019 (Q4 FY 2019).
Aug 21, 2019 04:30 pm ET
Electromed, Inc. Announces Home Medical Equipment Distributor Partnerships
Electromed, Inc. (NYSE American: ELMD) today announced entry into agreement with two Home Medical Equipment (“HME”) distributors – one national and one regional – to distribute and sell the SmartVest® Airway Clearance System in the United States home care market. The Company expects to continue its direct sales channel as its primary homecare revenue source. Sale of the SmartVest system through HME distributors has begun in targeted geographies in the first quarter of fiscal 2020.
Aug 15, 2019 04:30 pm ET
Electromed, Inc. Names John Erb and Greg Fluet to its Board of Directors
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, announced today that its Board of Directors has elected each of John L. Erb and Gregory J. Fluet to serve as directors of the company.
Aug 13, 2019 04:30 pm ET
Electromed, Inc. Schedules Release of Fourth Quarter Fiscal 2019 Financial Results and Conference Call
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2019 fourth quarter ended June 30, 2019 on Tuesday, August 27, 2019 after the close of the stock market. Management will host a conference call on Wednesday, August 28, 2019 at 9:00 a.m. Eastern Time to discuss the results.
Jun 27, 2019 09:00 am ET
First-Of-Its-Kind Independent Study Finds SmartVest® Reduces Exacerbations, Antibiotic Use, and Stabilizes Lung Function as Part of a Treatment Algorithm
“Our study demonstrates an algorithm of care emphasizing chest physiotherapy improves key outcomes including hospitalizations for patients with non-CF bronchiectasis,” said George Solomon, MD, University of Alabama at Birmingham, and lead investigator of the study.
May 07, 2019 04:30 pm ET
Electromed, Inc. Announces Fiscal 2019 Third Quarter Financial Results
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway
clearance technologies, today announced financial results for the three
months ended March 31, 2019 (Q3 FY 2019).
Apr 25, 2019 04:30 pm ET
Electromed, Inc. Names Bud Reeves Vice President of Sales
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway
clearance technologies, today announced that Bud Reeves has joined the
Company as Vice President of Sales and will oversee all domestic sales
initiatives to accelerate revenue growth. Bud has over 20 years of sales
and marketing leadership experience in the healthcare industry and
brings a history of strong execution of growth strategies and proven
results, specifically in emerging respiratory markets.
Apr 24, 2019 04:30 pm ET
Electromed, Inc. Schedules Release of Third Quarter Fiscal 2019 Financial Results and Conference Call
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway
clearance technologies, today announced that it will issue its financial
results press release for the fiscal 2019 third quarter ended March 31,
2019 on Tuesday, May 7, 2019 after the close of the stock market.
Management will host a conference call on Wednesday, May 8, 2019 at 9:00
a.m. Eastern Time to discuss the results.
Mar 14, 2019 09:00 am ET
Electromed, Inc. To Participate in the Sidoti & Company Spring 2019 Conference
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway
clearance technologies, today announced that management will participate
in the Sidoti & Company Spring 2019 Conference in New York, NY on
Thursday, March 28, 2019.
Feb 12, 2019 04:30 pm ET
Electromed, Inc. Announces Fiscal 2019 Second Quarter Financial Results
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway
clearance technologies, today announced financial results for the three
months ended December 31, 2018 (Q2 FY 2019).
Jan 30, 2019 04:30 pm ET
Electromed, Inc. Schedules Release of Second Quarter Fiscal 2019 Financial Results and Conference Call
Electromed, Inc. (NYSE American:ELMD), a leader in innovative airway
clearance technologies, today announced that it will issue its financial
results press release for the fiscal 2019 second quarter ended December
31, 2018 on Tuesday, February 12, 2019 after the close of the stock
market. Management will host a conference call on Wednesday, February
13, 2019 at 9:00 a.m. Eastern Time to discuss the results.
Nov 13, 2018 04:30 pm ET
Electromed, Inc. Announces Fiscal 2019 First Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD),
a leader in innovative airway clearance technologies, today announced
financial results for the three months ended September 30, 2018 (“Q1 FY
2019”).
Oct 31, 2018 09:00 am ET
Electromed, Inc. Schedules Release of First Quarter Fiscal 2019 Financial Results and Conference Call
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway
clearance technologies, today announced that it will issue its financial
results press release for the fiscal 2019 first quarter ended September
30, 2018 on Tuesday, November 13, 2018 after the close of the stock
market. Management will host a conference call on Wednesday, November
14, 2018 at 9:00 a.m. Eastern Time to discuss the results.
Sep 25, 2018 04:30 pm ET
Electromed, Inc. Announces Fiscal 2018 Fourth Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD),
a leader in innovative airway clearance technologies, today announced
financial results for the three months ended June 30, 2018 (“Q4 FY
2018”).
Aug 30, 2018 09:00 am ET
Electromed, Inc. Schedules Release of Fourth Quarter Fiscal 2018 Financial Results and Conference Call
Electromed, Inc. (NYSE American:ELMD), a leader in innovative airway
clearance technologies, today announced that it will issue its financial
results press release for the fiscal 2018 fourth quarter ended June 30,
2018 on Tuesday, September 25, 2018 after the close of the stock market.
Management will host a conference call on Wednesday, September 26, 2018
at 9:00 a.m. Eastern Time to discuss the results.
Aug 14, 2018 04:15 pm ET
Electromed, Inc. Announces Results of an Independent Clinical Study: Bronchiectasis Exacerbations Reduced, Lung Function Stabilized with SmartVest®
Electromed, Inc. (NYSE American:ELMD) today announced the results of an
independent, outcome-based clinical study presented during the third
annual World Bronchiectasis Conference in Washington D.C. The study’s
findings reveal that early use of high frequency chest wall oscillation
(“HFCWO”) therapy with the SmartVest® Airway Clearance System
significantly reduced severe exacerbations and hospitalizations among
non-cystic fibrosis bronchiectasis patients. The study is the first to
report “stabilization of key lung function parameters”
May 23, 2018 04:30 pm ET
Electromed, Inc. to Receive Refund for Medical Device Excise Taxes Paid
Electromed, Inc. (NYSE American:ELMD) ("Electromed" or the "Company"), a
leader in innovative airway clearance technologies, today announced that
the Internal Revenue Services (“IRS”) has agreed to refund the Company
approximately $406,000 related to federal medical device excise taxes
paid on revenue associated with the sales of its SmartVest® Airway
Clearance System (“SmartVest”) during the Company's tax periods ended
June 30, 2014 through December 31, 2015. This refund from the IRS will
be recognized in the Company’s financial statements duri
May 08, 2018 04:30 pm ET
Electromed, Inc. Announces Fiscal 2018 Third Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:ELMD), a
leader in innovative airway clearance technologies, today announced
financial results for the three months ended March 31, 2018 (“Q3 FY
2018”).
Apr 26, 2018 04:10 pm ET
Electromed, Inc. Announces Results of a Longitudinal Outcome-Based Study: Bronchiectasis Exacerbations Significantly Reduced with HFCWO Therapy
Electromed, Inc. (NYSE American:ELMD) today announced the results of a
longitudinal outcome-based study published in Respiratory
Therapy: The Journal of Pulmonary Technique. The
longitudinal study shows that high frequen
Apr 25, 2018 04:05 pm ET
Electromed, Inc. Schedules Release of Third Quarter Fiscal 2018 Financial Results and Conference Call
Electromed, Inc. (NYSE American:ELMD), a leader in innovative airway
clearance technologies, today announced that it will issue its financial
results press release for the fiscal 2018 third quarter ended March 31,
2018 on Tuesday, May 8, 2018 after the close of the stock market.
Management will host a conference call on Wednesday, May 9, 2018 at 9:00
a.m. Eastern Time to discuss the results.
Feb 14, 2018 07:30 am ET
Electromed, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 14, 2018 / Electromed, Inc. (NYSE American: ELMD) will be discussing their earnings results in their Q2 Earnings Call to be held on February 14, 2018 at 9:00 AM Eastern Time.
Feb 13, 2018 04:30 pm ET
Electromed, Inc. Announces Fiscal 2018 Second Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:ELMD), a
leader in innovative airway clearance technologies, today announced
financial results for the three months ended December 31, 2017 (“Q2 FY
2018”).
Jan 31, 2018 05:15 pm ET
Electromed, Inc. Schedules Release of Second Quarter Fiscal 2018 Financial Results and Conference Call
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway
clearance technologies, today announced that it will issue its financial
results press release for the fiscal 2018 second quarter ended December
31, 2017 on Tuesday, February 13, 2018 after the close of the stock
market. Management will host a conference call on Wednesday, February
14, 2018 at 9:00 a.m. Eastern Time to discuss the results.
Nov 07, 2017 04:30 pm ET
Electromed, Inc. Announces Fiscal 2018 First Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:ELMD), a
leader in innovative airway clearance technologies, today announced
financial results for the three months ended September 30, 2017 (“Q1 FY
2018”).
Oct 25, 2017 09:10 am ET
Electromed, Inc. Schedules Release of First Quarter Fiscal 2018 Financial Results and Conference Call
Electromed, Inc. (NYSE American: ELMD), a leader in innovative airway
clearance technologies, today announced that it will issue its financial
results press release for the fiscal 2018 first quarter ended September
30, 2017 on Tuesday, November 7, 2017 after the close of the stock
market. Management will host a conference call on Wednesday, November 8,
2017 at 9:00 a.m. Eastern Time to discuss the results.
Oct 12, 2017 09:00 am ET
Electromed, Inc. Names Kathryn Thompson Vice President of Reimbursement
Electromed, Inc. (NYSE American: ELMD) today announced that Kathryn
Thompson has joined the Company as Vice President of Reimbursement and
will oversee all reimbursement, billing, and contracting functions.
Kathryn brings an extensive record of innovative, patient-focused
leadership to Electromed, having spent over 20 years in the healthcare
industry with a proven track record in the reimbursement revenue cycle,
as well as operations and finance.
Feb 28, 2017 02:34 pm ET
Titan Machinery Elects Two New Board Members
WEST FARGO, N.D., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Titan Machinery Inc. (NASDAQ:TITN) announced today that it has elected Stan Erickson and John Henderson, to its Board of Directors. Messrs. Erickson and Henderson’s respective terms on the Board of Directors will each begin March 1, 2017. With the election of Messrs. Erickson and Henderson, the Board will now consists of eight directors, including six independent directors....
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.